Amgen › Financials
Amgen financials
AMGNTen years from Amgen’s own SEC filings. Fiscal years end in December.
Income statement
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.99B | $22.85B | $23.75B | $23.36B | $25.42B | $25.98B | $26.32B | $28.19B | $33.42B | $36.75B | $38.09B | — |
| Operating income | $9.79B | $9.97B | $10.26B | $9.67B | $9.14B | $7.64B | $9.57B | $7.90B | $7.26B | $9.08B | $11.43B | — |
| Net income | $7.72B | $1.98B | $8.39B | $7.84B | $7.26B | $5.89B | $6.55B | $6.72B | $4.09B | $7.71B | $8.74B | — |
| Earnings per share, diluted | $10.24 | $2.69 | $12.62 | $12.88 | $12.31 | $10.28 | $12.11 | $12.49 | $7.56 | $14.23 | — | — |
Balance sheet
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.24B | $3.80B | $6.95B | $6.04B | $6.27B | $7.99B | $7.63B | $10.94B | $11.97B | $9.13B | — | $13.99B |
| Total assets | $77.63B | $79.95B | $66.42B | $59.71B | $62.95B | $61.16B | $65.12B | $97.15B | $91.84B | $90.59B | — | $95.64B |
| Debt | $34.60B | $35.34B | $33.93B | $29.90B | $32.99B | $33.31B | $38.95B | $64.61B | $60.10B | $54.60B | — | $57.30B |
| Total liabilities | $47.75B | $54.71B | $53.92B | $50.03B | $53.54B | $54.47B | $61.46B | $90.92B | $85.96B | $81.93B | — | $83.95B |
| Shareholders' equity | $29.88B | $25.24B | $12.50B | $9.67B | $9.41B | $6.70B | $3.66B | $6.23B | $5.88B | $8.66B | — | $11.69B |
Cash flow
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.35B | $11.18B | $11.30B | $9.15B | $10.50B | $9.26B | $9.72B | $8.47B | $11.49B | $9.96B | $12.48B | — |
| Capital spending | $738.0M | $664.0M | $738.0M | $618.0M | $608.0M | $880.0M | $936.0M | $1.11B | $1.10B | $1.86B | $2.30B | — |
| Free cash flow | $9.62B | $10.51B | $10.56B | $8.53B | $9.89B | $8.38B | $8.79B | $7.36B | $10.39B | $8.10B | $10.18B | — |
| Buybacks | $2.96B | $3.16B | $17.79B | $7.70B | $3.49B | $4.97B | $6.36B | $0 | $200.0M | $0 | — | — |
| Dividends | $3.00B | $3.37B | $3.51B | $3.51B | $3.75B | $4.01B | $4.20B | $4.56B | $4.83B | $5.12B | $5.29B | — |
| Returned to shareholders | $5.96B | $6.53B | $21.30B | $11.21B | $7.24B | $8.99B | $10.56B | $4.56B | $5.03B | $5.12B | $5.29B | — |
| Stock-based pay | $311.0M | $329.0M | $311.0M | $308.0M | $330.0M | $341.0M | $401.0M | $431.0M | $530.0M | $494.0M | $492.0M | — |
Where these numbers come from
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
Amgen financials, answered
What is Amgen's market cap?
$233.82B at $432.49 a share, with 540,632,005 shares outstanding as of Jul 30, 2026, from the cover of its latest SEC filing.
How much does Amgen earn?
Revenue of $38.09B and net income of $8.74B in the last 12 months to Jun 2026.
How much debt does Amgen have?
Amgen reported $57.30B of debt and $13.99B of cash and equivalents on its balance sheet in Jun 2026.
Does Amgen make free cash flow?
Yes. Operating cash flow minus capital spending was $10.18B in the last 12 months to Jun 2026.
How much cash does Amgen return to shareholders?
$5.12B in buybacks and dividends in fiscal 2025, from the cash flow statement.